Frailty and Oncology: An Increasingly Common Combination

It is crucial to acknowledge frailty as a pivotal clinical variable, rather than considering it a contraindication to cancer treatment. Health systems should promote structured frailty evaluation, professional training, and institutional pathways to ensure equitable, patient-centred management of frail individuals with cancer. Integrating frailty into oncology clinical practice operationalises personalised medicine by shifting the focus from treating the disease to treating the whole patient.